Andrew Baumgartner

发表

Machine learning to understand risks for severe COVID-19 outcomes: a retrospective cohort study of immune-mediated inflammatory diseases, immunomodulatory medications, and comorbidities in a large US health-care system

J. Hadlock, S. Molani, Wanessa F Matos, 2024, The Lancet. Digital health.

Risk factors for severe COVID-19 outcomes: a study of immune-mediated inflammatory diseases, immunomodulatory medications, and comorbidities in a large US healthcare system

J. Hadlock, S. Molani, Wanessa F Matos, 2023, medRxiv.